Novartis AG (NVS) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Basel, Switzerland. El CEO actual es Vasant Narasimhan.
NVS tiene fecha de IPO 1996-11-07, 75,883 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $296.06B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets a broad portfolio of prescription medicines and healthcare products worldwide. The company operates through two primary segments: Innovative Medicines, which focuses on specialty pharmaceuticals across therapeutic areas including oncology, immunology, neuroscience, ophthalmology, cardiovascular, and respiratory diseases, and Sandoz, a leading generics and biosimilars business that produces small molecule pharmaceuticals, active pharmaceutical ingredients, and biotechnology-based products. Novartis maintains strategic partnerships and collaborations with biotechnology companies to advance its clinical pipeline and expand treatment options for patients globally.
